Status
Conditions
Study type
Funder types
Identifiers
About
This is a safety follow-up study. Patients enrolled in B4711001 will be followed for a further 4 years with regular visits to assess safety.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
10 participants in 1 patient group
Loading...
Central trial contact
Declan Flanagan
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal